The 32 P-post-labelling assay for DNA adduct quantification gives the opportunity to examine endogenous exposure to DNA reactive compounds. Most human biomonitoring studies applied white blood cells (WBC) or cells obtained by broncho-alveolar lavages (BAL) as source of DNA, but still it is not clear what cell type represents the most reliable indicator for exposure to cigarette smoke-associated genotoxins. At first, we examined DNA adduct levels by means of nuclease P1 (NP1) enriched 32 P-post-labelling in separated WBC subpopulations after in vitro incubations for 18 h with 10 µM benzo[a]pyrene (B[a]P). DNA adduct levels were highest in monocytes (10.7 ⍨ 2.9 adducts/10 8 nucleotides, n ⍧ 8), followed by lymphocytes (5.9 ⍨ 1.7, n ⍧ 8), and granulocytes (0.5 ⍨ 0.2, n ⍧ 8). Secondly, aromatic-DNA adduct levels were determined in BAL cells and WBC-subsets from (non-)smoking volunteers. In smoking individuals, adduct levels were in the ranking order: BAL cells (3.7 ⍨ 1.0, n ⍧ 5) > monocytes (2.0 ⍨ 0.5, n ⍧ 8) ജ lymphocytes (1.6 ⍨ 0.4, n ⍧ 8) > granulocytes (0.8 ⍨ 0.2, n ⍧ 8) by NP1-enrichment and monocytes (9.0 ⍨ 3.2, n ⍧ 5) ജ lymphocytes (8.0 ⍨ 2.1, n ⍧ 6) > granulocytes (2.1 ⍨ 0.3, n ⍧ 7) by butanol-enriched 32 Ppost-labelling. Aromatic-DNA adduct levels were significantly higher in WBC-subsets of smokers as compared with non-smokers, except for DNA adducts in granulocytes using butanol enrichment. Thirdly, dose-response relationships were investigated in mononuclear white blood cells (MNC, i.e. monocytes plus lymphocytes) and BAL-cells of a larger group of smoking individuals (n ⍧ 78). Adduct levels in MNC were related to daily exposure to cigarettetar (r ⍧ 0.31, P Ͻ 0.01). Adduct levels in BAL cells seemed to be correlated with pack-years, but after correction for age this relationship was lost. Butanol extraction resulted in 5-6-fold higher DNA adduct levels in MNC, whereas butanol extraction of BAL-DNA of the same individuals yielded only 2-fold higher adduct levels. The two enrichment procedures of 32 P-post-labelling were correlated in BAL cells (r ⍧ 0.86, P Ͻ 0.001, n ⍧ 12). We conclude 
Introduction
The general population is exposed to polycyclic aromatic hydrocarbons (PAH*) via drinking water, food and polluted air (cigarette smoke). In tobacco smoke, over 40 compounds including PAH, tobacco specific nitrosamines and aromatic amines were found to elicit cancer in experimental animals. Recently, Denissenko et al. (1) confirmed that the environmental pollutant benzo[a]pyrene (B[a]P) plays an important role in the aetiology of lung cancer. PAHs exert their carcinogenic effects via covalent interactions of reactive metabolites with DNA. The resulting DNA adducts have been studied as a measure of the biologically effective dose and as an indicator for cancer risk in PAH treated animals (2-4). 32 P-post-labelling is frequently used to study carcinogen-DNA adducts in humans. It is sensitive and can be successfully applied to monitor exposure to complex mixtures. To enhance the sensitivity of this assay, adduct enrichment procedures are performed by either butanol extraction of adducted nucleotides, or by selective dephosphorylation of unadducted nucleotides by nuclease P1 (NP1). Overall, the butanol enhancement method seems to be more sensitive, but for assessing exposures to unknown chemical mixtures both enhancement methods are recommended (5) . Samples of target tissues are difficult to collect and white blood cells (WBC) are often used as a surrogate. The validity of measurements in surrogate sources of DNA, however, is a matter of discussion. In the human lung, hydrophobic aromatic DNA adduct levels appeared to be linearly related to the number of cigarettes smoked per day (6) . Conflicting results have been reported on the occurrence of PAH-DNA adducts in peripheral blood cells of smokers (7) (8) (9) (10) . No clear differences between PAH-DNA adduct levels in WBC of smokers and non-smokers have been found and, moreover, large inter-individual variations were observed. WBC can be divided in three subpopulations: short-living granulocytes (40-75%) and monocytes (5-10%), and long living lymphocytes (20-40%) . They also differ in metabolizing (11) and repair capacity (12) . Consequently, their contribution to DNA adduct concentrations in total WBC-DNA will be variable. Another surrogate source of exposed DNA is derived from cells obtained by bronchoalveolar lavages (BAL) as suggested by Izzotti et al. (13) and De Flora et al. (14) . Alveolar macrophages (AM), the predominant cell-type in BAL, can be considered as a non-peripheral subfraction of the WBC population, because these cells are thought to originate from peripheral blood monocytes that have left the circulation.
Although these various cell types have been applied in several human studies to assess the biologically effective dose, they were never compared in the same study. It was the aim of this study to examine the differences in aromatic DNA adduct levels of alveolar macrophages and subpopulations of 32 P-post-labelling with thin-layer chromatography (TLC). Subsequently, aromatic-DNA adduct levels were investigated in mononuclear white blood cells (MNC, i.e. monocytes plus lymphocytes) and BAL cells of a second, larger study population of healthy smokers (n ϭ 78) to establish doseresponse relationships. Furthermore, WBC subsets of nonsmoking volunteers were sampled to assess background levels of aromatic DNA adducts.
Materials and methods

Chemicals
All solutions used were sterile. B[a]P was purchased from Sigma (St Louis, MO, USA). RPMI 1640, streptomycin/penicillin, L-glutamine and foetal calf serum (FCS) were all obtained from Gibco (Europe). Lymphoprep TM (1.077 g/ml) was obtained from Nycomed (Oslo, Norway). All other chemicals were purchased from Merck (Darmstadt, Germany). Water was purified by means of a milli-Q purification system.
Study populations
The overall characteristics of the study populations are summarized in Table  I . Study population 'Maastricht' (MAAS-I) involves blood from eight healthy male, non-smoking volunteers (age: 27 Ϯ 2 years, range 23-36 years) and WBC-subpopulations of these individuals were in vitro exposed to B[a]P as described below. The second 'Maastricht' study population (MAAS-II) involves five male and 10 female putatively unexposed, non-smoking volunteers (age: 33 Ϯ 3, range 18-52). WBC-subpopulations of these individuals were used as control. In study population 'Lanaken' (LAN) blood and BAL was obtained from eight smoking male patients (age: 63 Ϯ 7, range 31-81) from the St Barbara Hospital (Lanaken, Belgium). BAL was performed in these individuals as a part of the diagnostic process in patients with putative pneumoconiosis, COPD or lung cancer. Patients with an active inflammatory process were excluded. Sampling of blood and BAL was performed from April to July 1995. Study population 'Amsterdam' (AMS) consisted of 26 male and 52 female healthy smoking volunteers (age: 43 Ϯ 9, range 25-64). Blood and BAL were sampled over the period October 1994 to September in 1995. These studies were approved by the medical ethical committees of the Netherlands Cancer Institute (AMS) and the Maastricht University (Maas I and II, LAN) and informed consent was obtained in all cases.
Isolation of subpopulations of human white blood cells for in vitro incubations
Fifty millilitres of peripheral blood of eight healthy non-smoking volunteers was sampled by venapuncture into EDTA-tubes. Polymorphonuclear cells (granulocytes) were separated from MNC by gradient centrifugation on lymphoprep according to Bøyum (15) . Both fractions were washed with PBS. The granulocyte fraction was treated with lysis buffer (155 mM NH 4 Cl, 10 mM KHCO 3 , 10 mM EDTA, pH 7.4) to lyse the erythrocytes and washed with PBS. In a next series of in vitro experiments, total white blood cells were collected after precipitation of erythrocytes in gelatin (1% w/v). The WBC were washed with PBS, 0.1% BSA, and separated into mononuclear cells and polymorphonuclear cells as described above.
In vitro treatment of white blood cells with benzo[a]pyrene
Cells were suspended at a concentration of 2ϫ10 6 cells/ml in RPMI 1640, supplemented with 10% FCS, 2 mM L-glutamine, 10 IU/ml penicillin and 10 µg/ml streptomycin. B[a]P was dissolved in dimethylsulphoxide (DMSO) and added to the cells to yield a final concentration of 10 µM. In all incubations the DMSO concentration did not exceed 0.5%. Cells were incubated for 18 h (37°C, 5% CO 2 :95% O 2 ). Viability was checked by means of trypan-blue exclusion. After the incubations, granulocytes and lymphocytes, were collected, centrifuged and washed twice with PBS. The remaining monocytes, which adhere to plastic surfaces, were washed twice with PBS buffer and immediately lysed within the TC-flask for DNA isolation.
Isolation of WBC subfractions of patients and healthy volunteers
Mononuclear white blood cells and granulocytes were isolated from 10 ml peripheral blood as described above. Monocytes and lymphocytes were resuspended in RPMI 1640 (supplemented with 10% FCS, 2 mM L-glutamine, 10 IU/ml penicillin and 10 µg/ml streptomycin) at a concentration of~1ϫ10 6 cells per ml and separated by adherence of monocytes to plastic TC-flasks for 40 min at 37°C. Cells were stored at -20°C until DNA-isolation.
Performance of the bronchoalveolar lavages
Bronchoscopy in the AMS study population was performed under local anaesthesia (lidocaine). The bronchoscope was placed into the right middle lobe bronchus and 180 ml of sterile saline (37°C) was instilled in nine aliquots of 20 ml each. The dwell time was~3 min. Bronchoalveolar lavages of the LAN study population was performed by introducing 50 ml of 0.9% normal saline into the lung. Then, immediately suction (60 mmHg) was applied. This procedure was performed four times. BAL fluids were directly collected in plastic tubes and placed on ice. Cells were counted and after centrifugation (4°C, 1500 g, 10 min), the cell pellet was stored at -70°C until DNA isolation. DNA isolation WBC-subpopulations were lysed with 2.5 ml SDS/NEP (75 mM NaCl, 25 mM EDTA, 50 µg/ml proteinase K, 1% SDS) and incubated for 4 h at 37°C. DNA was extracted with phenol:chloroform:isoamylalcohol (25:24:1, v/v/v) and chloroform:isoamylalcohol (24:1, v/v), respectively. The DNA was precipitated with two volumes of cold ethanol after addition of 1/30 volume 3 M sodium acetate, pH 5.3 and washed with 70% ethanol. Subsequently, DNA was dissolved in 2 mM Tris, pH 7.4. Concentration and purity were determined spectrophotometrically by absorbance at 230, 260 and 280 nm. The mean spectrophotometrical ratios of A260/A280 and A230/A260 were, respectively, 1.67 (range: 1.55-1.83) and 0.45 (0.42-0.50). The final volume was adjusted to achieve a DNA-concentration of 2 mg/ml. 32 
P-post-labelling
The 32 P-post-labelling assay was performed as described by Reddy and Randerath (16) with some modifications. All samples were analysed blindly. DNA (10 µg) was digested using micrococcal endonuclease (0.4 units) and spleen phosphodiesterase (2.8 µg) for 3 h at 37°C. Subsequently, half of the digest was treated with nuclease P1 (6.3 µg) for 40 min at 37°C. Butanol enrichment was performed according to Gallagher et al. (17) . The modified nucleotides were labelled with [γ-32 P]ATP (50 µCi/ sample) by incubation with T4-polynucleotide kinase (5.0 units) for 30 min at 37°C.
[γ-32 P]ATP was synthesized in the laboratory using carrier-free 32 P (Dupont, Brussels, specific activity: 8500-9120 Ci/mmol). NP1-efficiency and ATPexcess were checked with an aliquot of the NP1 treated fraction by onedimensional chromatography on poly(ethyleneimine)(PEI)-cellulose sheets from Merck, Germany (solvent: 0.12 M NaH 2 PO 4 pH 6.8). Radiolabelled adduct nucleotide biphosphates were separated by chromatography on PEIcellulose sheets from Machery Nagel (Germany). The following solvent systems were used: D1, 1 M NaH 2 PO 4 pH 6. pyrene-diol-epoxide (BPDE) modified DNA with known modification levels (1 per 10 7 , 10 8 , 10 9 nucleotides) were run in parallel for quantification purposes. Quantification was performed by using phosphorimaging technology (Molecular Dynamics™, Sunnyvale, CA, USA) with a detection limit of Ͻ1 adduct per 10 9 nucleotides for individual spots. The detection limit of a diagonal radioactive zone (DRZ) was around 5 adducts per 10 9 nucleotides. The remaining half of the digest was used to determine the final amount of DNA in the assay; the normal nucleotides were diluted and labelled with [γ-32 P]ATP (15 µCi/ sample) by incubation with T4-polynucleotide kinase (2.5 units) and a 10-fold molar excess of unlabelled ATP for 30 min at 37°C. A dAp standard (27.5 pmol/µl) was labelled in each experiment for quantification purposes. Nucleotides were separated by onedimensional chromatography on PEI-cellulose sheets from Merck (solvent: 0.12 M NaH 2 PO 4 pH 6.8); samples with apparent protein or RNA contamination were discarded.
Statistics
Results are presented as mean Ϯ standard error of the mean. Non-parametrictests were applied for differences between blood cell subsets (Wilcoxon, paired samples) and for comparison of smokers versus non-smokers (Mann-Whitney, unpaired samples). Linear regression was used to assess the relations between cell-types, enrichment procedures and to assess doseresponses. P Ͻ 0.05 was considered significant.
Results
In vitro treatment of white blood cells with B[a]P
After 18 h of in vitro incubation with B[a]P, the predominant adduct detected in DNA of human WBC-subpopulations comigrated with the major adduct of the [ 3 H]BPDE-DNA standard, putatively BPDE covalently linked with deoxyguanosine (BPDE-dG), as shown in the adduct profiles of Figure 1 (panel E). Highest DNA adduct levels were found in monocytes, 10.7 Ϯ 2.9 BPDE-DNA/10 8 nucleotides (range 3.0-25.3), followed by lymphocytes, 5.9 Ϯ 1.7 BPDE-DNA/10 8 nucleotides (range 0.6-12.8), whereas granulocyte DNA contained substantially lower levels, 0.5 Ϯ 0.2 BPDE-DNA/10 8 nucleotides (range 0.04-1.7), using the NP1 method for DNA adduct enrichment (Figure 2 ). Adduct levels in monocytes and lymphocytes differed significantly from adduct levels in granulocytes (respectively, P ϭ 0.012 and P ϭ 0.008). Most individuals (seven out of eight) showed higher adduct levels upon in vitro incubation in monocytes as compared with lymphocytes, although the means did not differ significantly. Large interindividual variations were observed; 8-, 20-and 42-fold differences in, respectively, monocytes, lymphocytes and granulocytes (percentage of variance were, respectively, 76, 83 and 135%). To assess the total experimental variation of the in vitro experiment, lymphocytes obtained from five healthy male volunteers, were exposed to B[a]P in triplicate and analysed for DNA adducts using the NP1 enriched 821 32 P-post-labelling assay; the mean coefficient of variation was 18.2 Ϯ 2.9% (range: 2-40%, n ϭ 5) for parallel experiments.
After separation of the polymorphonuclear cells and mononuclear cells, the granulocytes were treated with lysis buffer to remove the erythrocytes. To exclude an effect of lysis buffer on the PAH-DNA adduct-forming capacity of granulocytes, in a separate set of experiments (n ϭ 3) the erythrocytes were removed from the diluted whole blood by gelatin precipitation. Using this less dramatic method for erythrocyte removal, the results were similar (data not shown).
Adducts in WBC and BAL in vivo in (non-)smoking humans
In smoking individuals (LAN-study population, Table I ) diagonal radioactive zones (DRZ) were found, which are typical for exposure to cigarette smoke (Figure 1, panel A and  B) . In monocytes and lymphocytes, but not in granulocytes of some individuals (five out of eight) also distinct adduct spots were observed, of which some comigrated (three out of eight) with the BPDE-DNA adduct standard (Figure 1, panel C) . Total adduct levels were highest in, respectively, BAL-cells (3.7 Ϯ 1.0, n ϭ 5), peripheral blood monocytes (2.0 Ϯ 0.5, n ϭ 8), lymphocytes (1.6 Ϯ 0.4, n ϭ 8) and granulocytes (0.8 Ϯ 0.2, n ϭ 8, P Ͻ 0.05) using NP1 enriched 32 P-postlabelling ( Figure 2) . Similarly, butanol extraction resulted in DRZ's and distinct adduct spots ( Figure 1 , panels F, G and H), although individual adduct profiles were not always identical when compared with the NP1-method. For example, adduct spots in lymphocytic DNA as shown in Figure 1 , panel H, were found in this subject after application of butanol extraction, whereas after NP1 enrichment a DRZ was observed. To ensure that the observed adduct spots were no background spots, as occasionally seen with the butanol procedure, samples were analysed in two or three independent experiments. Furthermore, these spots were absent in control samples of the same experiment. Total adduct levels in WBC subsets were~6-fold higher by the butanol procedure as compared with NP1 enrichment: monocytes (9.0 Ϯ 3.2; n ϭ 5), lymphocytes (8.0 Ϯ 2.1; n ϭ 6) and granulocytes (3.0 Ϯ 0.9; n ϭ 7; Figure 2 ; the amount of BAL-DNA was too small for analysis by NP1 and butanol enrichment).
In DNA of WBC subsets of most non-smoking controls (12/15), neither DRZ's nor adduct spots were found by NP1 enrichment. For statistical reasons, adduct levels of these samples were arbitrarily set on half of the detection limit for DRZ's (0.25 adducts per 10 8 nt). In three non-smokers, a faint DRZ was observed and adduct levels were marginally increased above the detection limit. Mean aromatic DNA adduct levels in monocytes, lymphocytes and granulocytes were respectively 0.35 Ϯ 0.07, 0.34 Ϯ 0.05 and 0.33 Ϯ 0.04, which were significantly lower as compared with smoking individuals (monocytes: P Ͻ 0.01, lymphocytes: P Ͻ 0.001, granulocytes: P ϭ 0.034; Figure 2 ). When butanol enrichment was applied, adduct spots could be detected in 8/15 non-smokers ( Figure  1 ), but quantitative and qualitative differences between nonsmokers and smokers were present. In non-smokers, mean adduct levels were 1.7 Ϯ 0.3 in monocytes (n ϭ 4, P ϭ 0.021 as compared to smokers), 3.8 Ϯ 1.3 in lymphocytes (n ϭ 9, P ϭ 0.09) and 2.5 Ϯ 0.8 in granulocytes (n ϭ 9, P ϭ 0.56; Figure 2 ).
Dose-response relationships in MNC and BAL from smoking individuals
In the larger group of healthy smoking volunteers (Table I, AMS-study population) dose-response relationships between smoking and adduct levels in MNC and BAL were investigated. Overall, adduct levels in MNC and BAL were, respectively, 1.8 Ϯ 0.1 (n ϭ 78) adducts per 10 8 nucleotides and 6.3 Ϯ 0.4 (n ϭ 53) by NP1 enrichment. The butanol procedure resulted in respectively 8.2 Ϯ 0.8 (n ϭ 14) and 13.9 Ϯ 1.2 (n ϭ 20). The amounts of cigarettes consumed per day (cigarettes/day), exposure to cigarette-tar per day (mg tar/day; calculated on basis of cigarettes/day and the tar content of the cigarettes) and pack-years (daily cigarette consumption/20 multiplied with the number of years the individual smoked) were used as indices of exposure. Non-smoking individuals were excluded from the analysis (Table II) . A modest but significant linear relationship was observed between aromatic-DNA adduct levels in MNC determined by NP1 mediated 32 P-post-labelling and tar exposure (excluding non-smokers: r ϭ 0.31, P ϭ 0.005, Figure 3 ), but not cigarette consumption (r ϭ 0.18, Fig. 3 . Linear relationship between aromatic DNA adduct levels in MNC of smoking volunteers (AMS-study population) determined by NP1 enriched 32 P-post-labelling (adducts per 10 8 nt) and daily exposure to cigarette-tar (mg/day) (excluding non-smokers: r ϭ 0.31, P ϭ 0.005, n ϭ 78; including non-smokers: r ϭ 0.50, P ϭ 0.0001, n ϭ 93). The dashed line indicates the limit of detection (dl.). P ϭ 0.100) or pack-years (r ϭ 0.14, P ϭ 0.239). In some of the heavy smokers (>30 cigarettes/day) relatively low DNA adduct levels were found, that could possibly be explained by the low tar content of the cigarette brand they consumed.
Aromatic-DNA adduct concentrations in BAL-cells were not found to be related to the exposure level. After application of butanol extraction, a significant relationship was observed between DNA adduct levels in BAL cells and pack-years (r ϭ 0.561, P ϭ 0.01). However, pack-years were also correlated with age and additional statistical analysis by multiple regression showed that the levels of aromatic-DNA adducts in BALcells were age-dependent. Consequently, after correction for age the relationship between pack-years and DNA adducts in BAL disappeared. DNA adduct levels in BAL cells and MNC were not significantly interrelated (r ϭ 0.19, P ϭ 0.33).
Although DNA adduct levels in BAL cells after butanol enrichment were~2-fold higher as compared with NP1-enriched adduct levels, both enrichment procedures were highly correlated (r ϭ 0.86, P Ͻ 0.001, n ϭ 12). On the contrary, in MNC of smoking individuals, no such relationship could be observed (r ϭ 0.01, P ϭ 0.97, n ϭ 12). When sufficient amount of DNA was available then DNA samples were analysed in two or three independent experiments to assess inter-assay variation Ϯ SE for lymphocytic DNA 19.1 Ϯ 2.4% (53/78) and for BAL-DNA 10.9 Ϯ 2.5% (18/53).
Discussion
In this study, we examined DNA adduct levels in separated WBC (lymphocytes, monocytes or granulocytes) after exposure to B[a]P in vitro or cigarette smoke in vivo. DNA adduct levels were higher in human monocytes and lymphocytes compared with granulocytes after in vitro incubation with B[a]P and in smoking individuals the ranking order was BALcells > monocytes ജ lymphocytes > granulocytes. DNA adduct levels in the WBC were significantly higher in smokers as compared with non-smokers by NP1, as well as butanol enriched 32 P-post-labelling, except for aromatic-DNA adducts in granulocytes assessed by butanol enrichment. A substantial amount of data on the presence of PAH-DNA adducts in WBC has been collected during the last decade (7, 9, (18) (19) (20) (21) . The relationship between the level of external exposure and the biologically effective dose is uncertain, presumably because DNA adducts were measured in total WBC (18) (19) (20) (21) . Depending on a person's health, WBC subpopulations differ in life-time and relative quantities. Consequently, the contribution of WBC subpopulations to the amount of DNA adducts in total WBC is different and variable. Monocytes and granulocytes are short living, and DNA adducts in these cells are therefore expected to give information about recent PAH exposure. On the other hand, lymphocytes may live for years, and may reflect exposures that occurred both recently and in the past. Several human studies found that smoking-related DNA adduct levels, PAH-DNA adducts as well as 7-methylguanine levels, were lower in granulocytes when compared to lymphocytes (7, 22) . Some of the studies that compared WBC DNA from smokers and non-smokers by 32 P-post-labelling have shown conflicting results on the formation of DNA adducts (7, 9, 10, 23, 24) . Other studies suggest that adducts in WBC DNA may result from PAH sources other than tobacco smoking, for instance, oral or dermal exposure (25) (26) (27) (28) (29) (30) (33, 34) . It is shown that interindividual differences in in vitro formation of B[a]P-DNA adducts are genetically controlled (35) and that an increased carcinogen-DNA adduct formation may indicate a constitutionally enhanced lung cancer risk (36) (37) (38) .
In MNC a significant linear relationship was observed between exposure to cigarette tar and the levels of aromatic DNA adducts. This is in line with previous observations of a relationship between DNA adducts in lung tissue and the amount of cigarettes smoked per day (6, 24, 39) . Adduct levels in BAL-cells, predominantly alveolar macrophages, were higher than DNA adduct levels in WBC-subpopulations. Thus, BALcells may represent a more sensitive surrogate tissue, because at low levels of inhalatory exposure, aromatic DNA adducts in BAL cells may still be detectable and at the same time DNA adduct levels in peripheral WBC are below the detection limit of the techniques currently in use. On the contrary, no significant correlations were found between DNA adduct levels in BAL-cells and exposure to cigarette smoke, but as recently demonstrated by Van Schooten et al. (40) the absence of a quantitative relationship could be due to saturation of adduct formation at high exposure levels. BAL cells are directly and highly exposed to cigarette smoke and in the present study BAL cells of heavy smokers were used (Ͼ20 cigarettes/day), therefore saturation may have occurred. Aromatic-DNA adduct levels in BAL were positively correlated with age. In lung tissue, Tang et al. (41) recently found an inverse relationship between adduct levels and age. In other studies concerning lung tissue, no influence of age was reported (6, 24, 39) . Therefore, until now a possible relationship between DNA adduct levels in BAL cells and lung tissue remains unclear, and should be further investigated.
It has been reported that NP1 detects predominantly PAH, whereas butanol enrichment detects in addition to PAH also aromatic amines and nitroaromatics (5, 17) . In all cell types that were examined in the present study, adduct levels were higher by butanol as compared with NP1 enrichment, which was also found by Binkova et al. (18) in environmentally exposed individuals. However, other studies report the opposite for white blood cells (42) . This suggests that the formation of DNA adducts by aromatic amines or tobacco specific nitroaromatics is substantial, because differences between these two methods were 6-fold in MNC and 2-fold in BAL-cells. In the present study, aromatic-DNA adducts were detected in WBC of non-smokers by butanol enrichment, but not by the NP1-method. Apparently, for reasons unknown, the NP1-method seems to be more specific for tobacco smoke exposure. In BAL-cells, but not in MNC, a significant correlation was observed between NP1 and butanol enrichment. This can be explained by the fact that DNA adducts in BAL-cells mainly represent exposure by inhalation, although in BAL cells no clear dose-response with smoking was observed. On the other hand, DNA adduct levels in WBC may originate from different sources such as inhalation or ingestion of food-borne carcinogens. These differences in exposure source could also explain the absence of a relationship between smoking behaviour and DNA adduct levels in MNC when butanol enrichment was applied.
Our results show that mononuclear cell fractions should be used for monitoring exposure to PAH. Application of BALcells might represent a more sensitive and specific surrogate for inhaled PAH, but further studies are necessary.
